| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PFIZER INC | President R&D | Common Stock | 322K | $8.7M | $27.04 | Feb 28, 2024 | Direct |
| PFIZER INC | President R&D | Phantom Stock Units | 87.6K | $2.52M | $28.79 | Dec 15, 2023 | Direct |
| AGILENT TECHNOLOGIES, INC. | Director | Common Stock | 5.71K | $842K | $147.48 | Mar 15, 2024 | Direct |
| ROCKET PHARMACEUTICALS, INC. | Director | Stock Option (Right to Buy) | 23K | $346K | $15.04 | Sep 9, 2024 | Direct |
| PFIZER INC | President R&D | Common Stock | 1.98K | $53.6K | $27.04 | Feb 28, 2024 | By Rule 16b-3 Plan |
| PFIZER INC | President R&D | Stock Appreciation Rights | 127K | Sep 12, 2024 | Direct | ||
| Karyopharm Therapeutics Inc. | Director | Nonstatutory Stock Option (right to buy) | 23.9K | May 21, 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| PFE | PFIZER INC | Sep 12, 2024 | 4 | $0 | 4 | Sep 16, 2024 | President R&D |
| RCKT | ROCKET PHARMACEUTICALS, INC. | Sep 9, 2024 | 2 | $0 | 4 | Sep 11, 2024 | Director |
| RCKT | ROCKET PHARMACEUTICALS, INC. | Sep 5, 2024 | 0 | $0 | 3 | Sep 11, 2024 | Director |
| A | AGILENT TECHNOLOGIES, INC. | Mar 15, 2024 | 1 | $247K | 4 | Mar 19, 2024 | Director |
| PFE | PFIZER INC | Feb 28, 2024 | 1 | -$580K | 4 | Feb 29, 2024 | President R&D |
| PFE | PFIZER INC | Feb 27, 2024 | 2 | $0 | 4 | Feb 28, 2024 | President R&D |
| PFE | PFIZER INC | Feb 23, 2024 | 1 | -$689K | 4 | Feb 27, 2024 | President R&D |
| PFE | PFIZER INC | Dec 15, 2023 | 1 | $1M | 4 | Dec 19, 2023 | President R&D |
| A | AGILENT TECHNOLOGIES, INC. | Mar 16, 2023 | 1 | $227K | 4 | Mar 20, 2023 | Director |
| PFE | PFIZER INC | Feb 25, 2023 | 1 | -$1.55M | 4 | Feb 28, 2023 | President R&D |
| PFE | PFIZER INC | Feb 22, 2023 | 3 | -$1.38M | 4 | Feb 24, 2023 | President R&D |
| PFE | PFIZER INC | Nov 7, 2022 | 4 | $2.63M | 4 | Nov 9, 2022 | President R&D |
| PFE | PFIZER INC | May 11, 2022 | 7 | -$2.4M | 4 | May 12, 2022 | President R&D |
| A | AGILENT TECHNOLOGIES, INC. | Mar 17, 2022 | 1 | $244K | 4 | Mar 21, 2022 | Director |
| PFE | PFIZER INC | Mar 3, 2022 | 4 | $3.26M | 4 | Mar 4, 2022 | President R&D |
| PFE | PFIZER INC | Feb 26, 2022 | 1 | -$1.42M | 4 | Mar 1, 2022 | President R&D |
| PFE | PFIZER INC | Feb 23, 2022 | 3 | -$1.4M | 4 | Feb 25, 2022 | President R&D |
| PFE | PFIZER INC | Dec 17, 2021 | 3 | $648K | 4 | Dec 21, 2021 | President R&D |
| PFE | PFIZER INC | Nov 11, 2021 | 14 | -$386K | 4 | Nov 15, 2021 | President R&D |
| A | AGILENT TECHNOLOGIES, INC. | Sep 22, 2021 | 1 | $97.8K | 4 | Sep 23, 2021 | Director |
| A | AGILENT TECHNOLOGIES, INC. | Sep 21, 2021 | 0 | $0 | 3 | Sep 23, 2021 | Director |
| KPTI | Karyopharm Therapeutics Inc. | May 21, 2021 | 1 | $0 | 4 | May 21, 2021 | Director |